Identification and sequence composition characterization of chondroitin sulfate-binding peptides through peptide array screening

Biochemistry

Volumn 49, Issue 7, 2010, Pages 1549-1555

  Butterfield, Karen Chao ^a   Caplan, Michael ^a   Panitch, Alyssa ^b  

^a Arizona State University   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CAPILLARY ELECTROPHORESIS; AFFINITY PEPTIDES; AROMATIC AMINO ACID; BINDING AFFINITIES; BINDING PEPTIDE; BINDING PROTEINS; CHONDROITIN SULFATES; COMPOSITION ANALYSIS; COMPOSITIONAL CHARACTERIZATION; CRITICAL AMINO ACIDS; DISEASE PROCESS; GLYCOSAMINOGLYCANS; HIGH AFFINITY; HIGH RATE; PEPTIDE ARRAYS; PEPTIDE SEQUENCES; POINT MUTATIONS; SPINAL CORD INJURY; STATISTICAL ANALYSIS; THERAPEUTIC USE;

AMINO ACIDS; BINDING ENERGY; CAPILLARY ELECTROPHORESIS; DIAGNOSIS; ORGANIC ACIDS; SULFUR COMPOUNDS;

PEPTIDES;

BINDING PROTEIN; CHONDROITIN SULFATE; CHONDROITIN SULFATE BINDING PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID COMPOSITION; ARTICLE; BINDING AFFINITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN MOTIF;

AMINO ACID MOTIFS; AMINO ACIDS, AROMATIC; AMINO ACIDS, BASIC; ANIMALS; CHONDROITIN SULFATES; CYCLIC AMP; DISACCHARIDES; ELECTROPHORESIS, CAPILLARY; FLUORESCENT DYES; PEPTIDES; POINT MUTATION; PROTEIN ARRAY ANALYSIS; PROTEIN BINDING; SHARKS;

EID: 77449096587     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi9021044     Document Type: Article

References (36)

1. Timar, J., Ladanyi, A., Lapis, K., and Moczar, M. (1992) Differential expression, of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential, Am. J. Pathol. 141, 467-474.
2. Nikitovic, D., Assouti, M., Sifaki, M., Katonis, P., Krasagakis, K., Karamanos, N. K., and Tzanakakis, G. N. (2008) Chondroitin sulfate and heparan sulfate-containing proteoglycans are both partners and targets of basic fibroblast growth, factor-mediated proliferation in. human metastatic melanoma cell lines. Int. J. Biochem. Cell Biol. 40, 72-83.
3. Properzi, F., Carulli, D., Asher, R. A., Muir, E., Camargo, L. M., van Kuppevelt T. H., ten Dam, G. B., Furukawa, Y., Mikami, T., Sugahara, K., Toida, T., Geller, H. M., and Fawcett, J. W. (2005) Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia. Eur. J. Neurosci. 21, 378-390.
4. Gilbert, R. J., McKeon, R. J., Darr, A., Catabro, A., Hascall, V. C., and Bellamkonda, R. V. (2005) CS-4,6 is differentially upregulated in glial, scar and is a potent inhibitor of neurite extension. Mol. Cell, Neurosci. 29, 545-558.
5. Bradbury, E. J., Moon, L. D., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., and McMahon, S. B. (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636-640.
6. Capita, I., and Linhardt, R. J. (2002) Heparin-protein interactions. Angew. Chem., Int. Ed. Engl. 41, 391-412.
7. Gama, C. I., Tully, S. E., Sotogaku, N., Clark, P. M., Rawat, M., Vaidehi, N., Goddard, W. A., III, Nishi, A., and Hsieh-Wilson, L. C. (2006) Sulfation patterns of glycosaminoglycans encode molecular recognition and activity. Nat. Chem. Biol. 2, 467-473.
8. Raman, R., Sasisekharan, V., and Sasisekharan, R. (2005) Structural insights into biological roles of protein-glycosaminoglycan interactions, Chem Biol. 12, 267-277.
9. Bingley, J. A., Hayward, I. P., Campbell, G. R., and Campbell, J. H. (2001) Relationship of glycosaminoglycan and matrix changes to vascular smooth, muscle cell phenotype modulation in rabbit arteries after acute injury. J. V. asc. Surg. 33, 155-164.
10. Theocharis, A. D., Theocharis, D. A., De Luca, G., Hjerpe, A., and Karamanos, N. K. (2002) Compositional and structural alterations of chondroitin and dermatan. sulfates during the progression of atherosclerosis and aneurysmal dilatation of the human abdominal aorta. Biochimie 84, 667-674.
11. Pins, G. D., Christiansen, D. L., Patel, R., and Silver, F. H. (1997) Self-assembly of collagen fibers. Influence of fibrillar alignment and decorin on mechanical properties. Biophys. J. 73, 2164-2172.
12. Keiser, N., Venkataraman, G., Shriver, Z., and Sasisekharan, R. (2001) Direct isolation and sequencing of specific protein-binding glycosaminoglycans. Nat. Med. 7, 123-128.
13. Tully, S. E., Rawat, M., and Hsieh-Wilson, L. C. (2006) Discovery of a TNF-alpha antagonist using chondroitin sulfate microarrays. J. Am. Chem. Soc. 128, 7740-7741.
14. Sorrell, J. M., Carrino, D. A., Baber, M. A., Asselineau, D., and Caplan, A. I. (1999) A monoclonal antibody which recognizes a glycosaminoglycan epitope in both dermatan sulfate and chondroitin sulfate proteoglycans of human skin. Histochem. J. 31, 549-558.
15. Resende, M., Nielsen, M. A., Dahlback, M., Ditlev, S. B., Andersen, P., Sander, A. F., Ndam, N. T., Theander, T. G., and Salanti, A. (2008) Identification, of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration, ligand, VAR2CSA. Malar. J. 7, 104.
16. Pothacharoen, P., Kalayanamitra, K., Deepa, S. S., Fukui, S., Hattori, T., Fukushima, N., Hardingham, T., Kongtawelert, P., and Sugahara, K, (2007) Two related but distinct chondroitin sulfate mimetope octasaccharide sequences recognized by monoclonal antibody WF6. J. Biol. Chem. 282, 35232-35246.
17. Purushothaman, A., Fukuda, J., Mizumoto, S., ten Dam, G. B., van Kuppevelt, T. H., Kitagawa, H., Mikami, T., and Sugahara, K. (2007) Functions of chondroitin sulfate/dermatan sulfate chains in brain development. Critical roles of E and iE disaccharide units recognized by a single chain, antibody GD3G7. J. Biol. Chem. 282, 19442-19452.
18. ten. Dam, G. B., van de Westerlo, E. M., Purushothaman, A., Stan, R. V., Bulten, J., Sweep, F. C., Massuger, L. F., Sugahara, K., and van Kuppevelt, T. H. (2007) Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian, cancer and involved in. vascular endothelial growth factor binding, Am. J. Pathol. 171, 1324-1333.
19. Smetsers, T. F., van de Westerlo, E. M., ten Dam, G. B., Clarijs, R., Versteeg, E. M., van Geloof, W. L., Veerkamp, J. H., van Muijen, G. N., and van Kuppevelt, T. H. (2003) Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma, Cancer Rgs. 63, 2965-2970.
20. Smetsers, T. F., van de Westerlo, E. M., ten Dam, G. B., Overes, I. M., Schalkwijk, J., van Muijen, G. N., and van Kuppevelt, T. H. (2004) Human single-chain antibodies reactive with, native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis. J. Invest. Dermatol, 122, 707-716.
21. Gao, X., Pellois, J. P., Na, Y., Kim, Y., Gulari, E., and Zhou, X. (2004) High density peptide microarrays. In situ synthesis and applications. Mol. Divers. 8, 177-187.
22. Frank, R. (2002) The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J. Immunol. Methods 267, 13-26.
23. Kramer, A., and Schneider-Mergener, J. (1998) Synthesis and screening of peptide libraries on continuous cellulose membrane supports. Methods Mol. Biol. 87, 25-39.
24. Margalit, H., Fischer, N., and Bensasson, S. A. (1993) Comparative analysis of structurally defined heparin-binding sequences reveals a distinct spatial distribution of basic residues. J. Biol. Chem, 268, 19228-19231.
25. Fromm, J. R., Hileman, R. E., Caldwell, E. E., Weiler, J. M., and Linhardt, R. J. (1997) Pattern and spacing of basic amino acids in heparin binding sites, Arch Biochem. Biophys. 343, 92-100.
26. Bae, J., Desai, U. R., Pervin, A., Caldwell, E. E., Weiler, J. M., and Linhardt, R. J. (1994) Interaction of heparin with, synthetic antithrombin III peptide analogues. Biochem. J. 301 (Part 1), 121-129.
27. McKeon, J., and Holland, L. A. (2004) Determination of dissociation constants for a heparin-binding domain of amyloid precursor protein and heparins or heparan sulfate by affinity capillary electrophoresis. Electrophoresis 25, 1243-1248.
28. Thai,C. K., Dai, H., Sastry, M.S., Sarikaya, M., Schwartz, D.T., and Baneyx, F. (2004) Identification and characterization of Cu(2)O- and ZnO-binding polypeptides by Escherichia coli cell surface display: toward an understanding of metal oxide binding. Biotechnol. Bioeng. 87, 129-137.
29. Cardin, A. D., and Weintraub, H. J. (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9, 21-32.
30. Caldwell, E. E., Nadkami, V. D., Fromm, J. R., Linhardt, R. J., and Weiler, J. M. (1996) Importance of specific amino acids in protein binding sites for heparin and heparan sulfate. Int. J. Biochem. Cell Biol. 25, 203-216.
31. Tyler-Cross, R., Sobel, M., McAdory, L. E., and Harris, R. B. (1996) Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes, Arch. BioChem Biophys. 334, 206-213.
32. Sasisekharan, R., Raman, R., and Prabhakar, V. (2006) Glycomics approach to structure-function relationships of glycosaminoglycans. Annu. Rev. Biomed. Eng. 8, 181-231.
33. Hileman, R. E., Fromm, J. R., Weiler, J. M., and Linhardt, R. J. (1998) Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bio Essays 20, 156-167.
34. Jeong, K. J., Butterfield, K., and Panitch, A. (2008) A novel assay to probe heparin-peptide interactions using pentapeptide-stabilized gold nanoparticles. Langmuir 24, 8794-8800.
35. Fromm, J. R., Hileman, R. E., Caldwell, E. E. O., Weiler, J. M., and Linhardt, R. J. (1995) Differences in the interaction of heparin with arginine and lysine and the importance of these basic-amino-acids in the binding of heparin to acidic fibroblast growth factor. Arch. Biochem. Biophys. 323, 279-287.
36. Shen, Y., Tenney, A. P., Busch, S. A., Horn, K. P., Cuascut, F. X., Liu, K., He, Z., Silver, J., and Flanagan, J. G. (2009) PTPsigma is a receptor for chondroitin sulfate proteoglycan an inhibitor of neural regeneration. Science 326, 592-596.